2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Names and Identifiers

Name	Phentolamine Mesylate
Synonyms	REGITIN VASOMAX REGITIN MESYLATE phentolamine mesilate Phentolamine Mesylate PHENTOLAMINE MESILATE PHENTOLAMINE MESYLATE phenomonomethanesulfonate PHENTOLAMINE METHANESULFONATE phentolaminemethanesulphonate phentolamine methanesulfonate Phentolamine methanesulfonate salt PHENTOLAMINE METHANESULFONATE SALT m-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)- m-(n-(2-imidazolin-2-ylmethyl)-p-toluidino)-phenomonomethanesulfonate(sal
CAS	65-28-1
EINECS	200-604-6
InChI	InChI=1/C17H19N3O.CH4O3S/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15;1-5(2,3)4/h2-8,11,21H,9-10,12H2,1H3,(H,18,19);1H3,(H,2,3,4)
InChIKey	OGIYDFVHFQEFKQ-UHFFFAOYSA-N

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Physico-chemical Properties

Molecular Formula	C18H23N3O4S
Molar Mass	377.46
Density	1.2256 (rough estimate)
Melting Point	180-182°C(lit.)
Boling Point	551°C at 760 mmHg
Flash Point	287°C
Water Solubility	50 mg/mL
Solubility	ethanol: soluble26 mg/mL H2O: soluble50 mg/mL
Vapor Presure	9.48E-13mmHg at 25°C
Appearance	powder
Color	white to off-white
Merck	14,7264
Storage Condition	2-8°C
Stability	Aq. Solutions Cannot be Stored
Refractive Index	1.6320 (estimate)
MDL	MFCD00134201
Use	α-adrenoceptor antagonist; peripheral vascular dilator.

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Risk and Safety

Risk Codes	R20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. R36/37/38 - Irritating to eyes, respiratory system and skin.
Safety Description	S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing.
UN IDs	3249
WGK Germany	3
RTECS	SL5430000
HS Code	29332900
Hazard Class	6.1(b)
Packing Group	III
Toxicity	LDLo scu-rat: 275 mg/kg NIIRDN 6,667,82

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Standard

Authoritative Data Verified Data

This product is 3-[[(4, 5-dihydro-1h-imidazol-2-yl) methyl] (4-tolyl) amino] phenol methanesulfonate. Calculated as dry product, containing not less than 99.0% of C17H19N30 • CH403S.

Last Update：2024-01-02 23:10:35

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Trait

Authoritative Data Verified Data

This product is white or white crystalline powder; Odorless.
This product is soluble in water or ethanol, slightly soluble in chloroform.

melting point

The melting point of this product (General rule 0612) is 176~181°C, and it is decomposed at the same time during melting.

Last Update：2022-01-01 11:38:57

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Differential diagnosis

Authoritative Data Verified Data

take about 30mg of this product, add 15ml of water to dissolve it, divide it into three parts, add iodine test solution, potassium iodide test solution and trinitrophenol test solution respectively, and produce brown precipitate, white precipitate and yellow precipitate respectively.
take 50mg of this product and 0.2g of sodium hydroxide, add several drops of water to dissolve, steam dry with small fire, then slowly heat to melt, continue to heat for several minutes, and let cool, add 0.5ml of water with a slight excess of dilute hydrochloric acid, heating, namely the occurrence of sulfur dioxide gas odor.
The infrared absorption spectrum of this product should be consistent with that of the reference substance phentolamine mesylate (General rule 0402).

Last Update：2022-01-01 11:38:58

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Exam

Authoritative Data Verified Data

pH

take 0.10g of this product, Add 10ml of water to dissolve, add 1 drop of Methyl red indicator liquid, should be red; Add sodium hydroxide titration solution (0.lmol/L)0.05, should become yellow.

chloride

take 0.10g of this product, add 5M l of water and 1ml of dilute nitric acid, warm to 80°C, add 1ml of silver nitrate test solution, and no white turbidity.

Related substances

take about 10mg of this product, put it in a 10ml measuring flask, add the mobile phase to dissolve and dilute to the scale, shake well, and use it as a test solution. Take 1 ml for precision measurement and put it in a 100ml measuring flask, dilute to the scale with the mobile phase, shake, and serve as a control solution. According to the chromatographic conditions under the content determination item, 20 u1 of each of the test solution and the control solution are accurately measured and injected into the human liquid chromatograph respectively, and the chromatogram is recorded to 5 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.5 times (0.5%) of the area of the main peak of the control solution, the sum of each impurity peak area shall not be greater than the main peak area of the control solution (1.0%). The chromatogram of the test solution is 0.02 times smaller than the main peak area of the control solution.

residual solvent

take an appropriate amount of this product, precision weighing, add an appropriate amount of N, N-dimethylformamide, immediately shake to dissolve and dilute to make about 0 per lml. lg solution, as the test solution; Another precision weighing methanol, ethanol, ethyl acetate and xylene appropriate amount, add N, N-dimethylformamide was dissolved and diluted to prepare a solution containing 0.3mg of toluene, 0.5mg of ethanol, 0.5mg of ethyl acetate and 0.217mg of xylene per 1 ml as a control solution. According to the determination method of residual solvent (General 0861 third method), 100% dimethyl polysiloxane is used as stationary liquid; The starting temperature is 40°C, and the temperature is raised to 80°C at the rate of 15 * C per minute for 5 minutes, then, the temperature is raised to 130°C at a rate of 6°C per minute for 1 minute, and then raised to 220°C at a rate of 40°C per minute for 3 minutes; The temperature of the injection port is 200°C; the detector temperature was 250°C. Take 1ul of reference solution and inject it into human gas chromatograph, and the separation degree between peaks of each component shall meet the requirements. 1 u1 of the test solution and the reference solution were respectively injected into the human Gas Chromatograph. The chromatogram was recorded and the peak area was calculated according to the external standard method. Methanol, ethanol, ethyl acetate and xylene residues shall be in accordance with the provisions.

loss on drying

take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).

ignition residue

not more than 0.1% (General rule 0841).

Last Update：2022-01-01 11:38:59

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Content determination

Authoritative Data Verified Data

measured by high performance liquid chromatography (General 0512).

chromatographic conditions and system suitability test

silica gel bonded with eighteen alkyl silane as a filler; 0.Olmol/L heptane sulfonate solution (containing 0. 1% triethylamine, adjusted to pH 3.0 with phosphoric acid)-acetonitrile (64:36) as mobile phase; The detection wavelength was 278nm. Take about 25mg of phentolamine mesylate reference substance, put it in a 25ml measuring flask, add 0.05 ml of 0.5 mol/L sodium hydroxide solution, and place it for 24 hours to degrade part of phentolamine mesylate into impurity I, 0.5ml of 0.05mol/L hydrochloric acid solution was added and neutralized, diluted with mobile phase to scale, and then shaken, and 20u1 of the solution was injected into human liquid chromatograph, the degree of separation between the phentolamine peak and the impurity I Peak (the main degradation product adjacent to the phentolamine peak is impurity I) shall be satisfactory. The number of theoretical plates is not less than 3000 calculated from the phentolamine peak.

assay

take about 25mg of this product, precision weighing, put in 25ml measuring flask, add water to dissolve and dilute to the scale, shake, take 5ml precision, put in 50ml measuring flask, dilute to scale with water, shake well, take 20 u1 with precision, inject human liquid chromatograph, record chromatogram; Take phentolamine mesylate reference substance, and determine with the same method. According to the external standard method, the peak area of phentolamine was calculated.

Last Update：2022-01-01 11:38:59

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Category

Authoritative Data Verified Data

a adrenergic receptor blockers.

Last Update：2022-01-01 11:39:00

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Storage

Authoritative Data Verified Data

light shielding, sealed storage.

Last Update：2022-01-01 11:39:00

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - PhentolamineMesylateTablets

Authoritative Data Verified Data

This product contains phentolamine mesylate (C17H19N30 • CH403S) should be 93.0% ~ 107.0% of the label amount.

trait

This product is white or white-like tablets or orange-red tablets or film-coated tablets with colorants, white or white-like after removing the coating.

identification

take an appropriate amount of fine powder of this product (about 30mg equivalent to phentolamine mesylate), add 15ml of water, dissolve with shaking, filter, and divide the filtrate into three parts, add iodine test solution, potassium iodide test solution and trinitrophenol test solution respectively, A brown precipitate, a white precipitate and a yellow precipitate were generated, respectively.
take an appropriate amount of fine powder of this product (about 50mg equivalent to phentolamine mesylate) and 0.2g of sodium hydroxide, add several drops of water to dissolve, evaporate to dryness with small fire, slowly heat to melt, continue to heat for several minutes, and cool, add 0.5ml of water with a slight excess of dilute hydrochloric acid, heating, namely the occurrence of sulfur dioxide gas odor.
the solution under the content measurement was measured by ultraviolet-visible spectrophotometry (General 0401), and the maximum absorption was found at a wavelength of 278nm.
in the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.

examination

Related substances appropriate amount of fine powder of this product (about 10mg equivalent to phentolamine mesylate) was placed in a 10ml measuring flask, and the mobile phase was added to dissolve and dilute to the scale, shake and filter, the continuous filtrate was taken as the test solution; 1ml of the test solution was accurately measured, placed in a 100ml measuring flask, diluted to the scale with the mobile phase, and shaken to serve as a control solution. According to the chromatographic conditions under the content determination item, 20Mk of the test solution and the control solution are respectively injected into the human liquid chromatograph, and the chromatogram is recorded to 5 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the peak area of impurity I peak shall not be greater than the main peak area of the control solution (1.0% ) , the Peak area of other single impurity peaks shall not be greater than 0.5 times (0.5%) of the main peak area of the control solution, and the sum of the peak areas of each impurity shall not be greater than 2 times (2.0%) of the main peak area of the control solution. The sample solution chromatogram is smaller than the dissolution of the main peak area of the control solution. According to the dissolution and release determination method (the first method of the general rule 0931), water 1000ml is used as the dissolution medium, the rotation speed is 50 rpm, and the operation is carried out according to law. After 15 minutes, the appropriate amount of the solution is taken, filtered, and the appropriate amount of the filtrate is taken, the solution containing about 20ug phentolamine mesylate per 1ml was prepared by quantitative dilution with dissolution medium. The absorbance was measured at the wavelength of 278mn by UV-Vis spectrophotometry (General rule 0401), precision weighing, dissolution and quantitative dilution of dissolution medium to prepare about 20% solution per 1 ml, the same method to determine, calculate the dissolution of each tablet. The limit is 80% of the labeled amount and shall be in accordance with the provisions.
others shall be in accordance with the relevant provisions under the item of tablets (General rule 0101).

Content determination

measured by high performance liquid chromatography (General 0512).
chromatographic conditions and system suitability test using eighteen alkyl silane bonded silica gel as filler; 0.01mol/L sodium heptane sulfonate solution (containing 0.1% triethylamine, adjusted to pH 3.0 with phosphoric acid)-Acetonitrile (64:36) as mobile phase; The detection wavelength was 278nm. Take about 25mg of phentolamine mesylate reference substance, put it in a 25ml measuring flask, add 0.05 ml of 0.5 mol/L sodium hydroxide solution, and place it for 24 hours to degrade part of phentolamine mesylate into impurity I, add 0.05mol/L hydrochloric acid solution (ml), dilute to the scale with mobile phase, shake, and use 20u1 to inject human liquid chromatograph as the applicable solution for the system, the degree of separation between the phentolamine peak and the impurity I Peak (the main degradation product adjacent to the phentolamine peak is impurity I) shall be satisfactory. The number of theoretical plates is not less than 3000 calculated from the phentolamine peak.
determination: take an appropriate amount of fine powder of this product (about 25mg equivalent to phentolamine mesylate), weigh it accurately, put it in a 25ml measuring flask, add water to dissolve phentolamine mesylate and dilute it to the scale, shake it well and filter it, precisely take 5ml of continuous filtrate, put it in 50ml measuring flask, dilute it to scale with water, shake well, use it as sample solution, precisely take 20 u1, inject human liquid chromatograph, record chromatogram; take an appropriate amount of phentolamine mesylate reference substance, weigh it precisely, add water to dissolve and quantitatively dilute it to make it contain about 0 in 1 ml. lmg solution, the same method for determination. According to the external standard method, the peak area of phentolamine was calculated.

category

Same as phentolamine mesylate.

specification

(l)40mg (2)50mg

storage

light shielding, sealed storage.

Last Update：2022-01-01 11:39:01

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine Mesilate Injection

Authoritative Data Verified Data

This product is a sterile aqueous solution of phentolamine mesylate plus 5% dextrose. Containing phentolamine mesylate (C17H19N3O • CH4O3S) shall be between 95.0% and 105.0% of label load.

trait

This product is colorless to yellowish clear liquid.

identification

take about 3ml of this product, add 12ml of water to dilute, according to phentolamine mesylate under the item of identification (1) test, showed the same reaction.
in the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.

examination

the pH value should be 2.5 to 5.0 (General 0631).
relevant substances: take an appropriate amount of this product (about equivalent to 10 mg of phentolamine mesylate), put it in a 10ml measuring flask, dilute it with mobile phase until it is calibrated, shake well, and use it as a test solution, set in a 100ml measuring flask, dilute to the scale with the mobile phase, and shake to serve as a control solution. If there are impurity peaks in the chromatogram of the test solution, the sum of the area of each impurity peak shall not be greater than 2.5 times (2.5%) of the area of the main peak of the control solution. The chromatogram of the test solution is 0.02 times smaller than the main peak area of the control solution.
bacterial endotoxin this product, according to the law inspection (General 1143), per 1 mg phentolamine mesylate in the amount of endotoxin should be less than 5.0EU.
others should comply with the relevant provisions under injection (General 0102).

Content determination

take an appropriate amount of this product (about 10mg equivalent to phentolamine mesylate), put it in a 100ml measuring flask, dilute it to the scale with water, shake it well, and use it as a test solution, according to phentolamine mesylate content determination method under the item of determination, obtained.

category

Same as phentolamine mesylate.

specification

(l)lml:5mg (2)lml:lOmg

storage

light shielding, closed storage.

Last Update：2022-01-01 11:39:02

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine mesylate capsules

Authoritative Data Verified Data

This product contains phentolamine mesylate (C17H19N3O • CH4O3S) should be 93.0% ~ 107.0% of the label amount.

trait

The content of this product is white powder.

identification

take an appropriate amount of the content of this product (about 30mg equivalent to phentolamine mesylate), add 15ml of water, shake and dissolve, filter, and divide the filtrate into three parts, add iodine test solution, potassium iodide test solution and trinitrophenol test solution respectively, A brown precipitate, a white precipitate and a yellow precipitate were generated, respectively.
take an appropriate amount of the contents of this product (about 50mg equivalent to phentolamine mesylate) and 0.2g of sodium hydroxide, add a few drops of water to dissolve, evaporate to dryness with small fire, slowly heat to melt, continue heating for several minutes, and cool, add 0.5ml of water with a slight excess of dilute hydrochloric acid, heating, namely the occurrence of sulfur dioxide gas odor.
the solution under the content measurement was measured by ultraviolet-visible spectrophotometry (General 0401), and the maximum absorption was found at a wavelength of 278nm.
in the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.

examination

take the content of the related substances under the content determination item, weigh an appropriate amount (about 10mg equivalent to phentolamine mesylate) accurately, put it in a 10ml measuring flask, add the mobile phase to dissolve and dilute to the scale, shake well, filter and take the filtrate as the test solution; Take 1ml of the test solution accurately, put it in a 100ml measuring flask, dilute it to the scale with mobile phase, shake well, and use as the control solution. According to the chromatographic conditions under the content determination item, the test solution and the control solution are 20M1 respectively, and the human liquid chromatograph is injected respectively, and the chromatogram is recorded to 5 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the peak area of impurity I peak shall not be greater than the main peak area of the control solution (1.0%), the Peak area of other single impurity peaks shall not be greater than 0.5 times (0.5%) of the main peak area of the control solution, and the sum of the peak areas of each impurity shall not be greater than 2 times (2.0%) of the main peak area of the control solution. The chromatogram of the test solution is 0.02 times smaller than the main peak area of the control solution.
the dissolution of this product, according to the dissolution and release determination method (General rule 0931 first method>, with water 1000ml as the dissolution medium, the speed is 50 rpm, according to the law, after 15 minutes, take the appropriate amount of solution, filter, take the appropriate amount of filtrate, dilute quantitatively with dissolution medium to make a solution containing about 20ug of phentolamine mesylate per lml, according to UV-Vis spectrophotometry (General rule 0401), measure absorbance at 278nm wavelength; Take appropriate amount of phentolamine mesylate reference, the dissolution medium is added to dissolve and quantitatively dilute to prepare a solution containing about 20ug per 1 ml, which is determined by the same method, and the dissolution amount of each particle is calculated. The limit is 80% of the labeled amount and shall be in accordance with the provisions.
others should comply with the relevant provisions under the capsule (General 0103).

Content determination

measured by high performance liquid chromatography (General 0512).
chromatographic conditions and system suitability test using eighteen alkyl silane bonded silica as filler; 0.Olmol/L sodium heptane sulfonate solution (containing 0.1% triethylamine, adjusted to pH 3.0 with phosphoric acid)-acetonitrile (64:36) as mobile phase; The detection wavelength was 278nm. Take about 25mg of phentolamine mesylate reference substance, put it in a 25ml children's bottle, add 0.05 ml of 0.5 mol/L sodium hydroxide solution, and place it for 24 hours to degrade part of phentolamine mesylate into impurity I, add 0.05mol/L hydrochloric acid solution in ML, dilute to the scale with mobile phase, shake well, and use 20u1 to inject human liquid chromatograph, the degree of separation between the phentolamine peak and the impurity I Peak (the main degradation product adjacent to the phentolamine peak is impurity I) shall be satisfactory. The number of theoretical plates is not less than 3000 calculated from the phentolamine peak.
determine the contents under the item of loading difference, mix evenly, weigh an appropriate amount (about 25mg of phentolamine mesylate) accurately, and put it in a 25ml measuring flask, add water to dissolve phentolamine mesylate and dilute to the scale, shake well, filter, Take 5ml of continued filtrate precisely, put it in a 50ml measuring flask, dilute to the scale with water, shake well, as a test solution, take 20ul with precision, inject human liquid chromatograph, record chromatogram; Take appropriate amount of phentolamine mesylate reference substance, weigh accurately, add water to dissolve and quantitatively dilute to make about 0 in 1 ml. lmg solution, the same method for determination. According to the external standard method, the peak area of phentolamine was calculated.

category

Same as phentolamine mesylate.

specification

40mg

storage

light shielding, sealed storage.

Last Update：2022-01-01 11:39:03

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine mesylate for injection

Authoritative Data Verified Data

This product is a sterile freeze-dried product made of phentolamine mesylate plus an appropriate amount of mannitol. Containing phentolamine mesylate (C17H19N3O • CH4O3S) shall be between 90.0% and 110.0% of label load.

trait

This product is a loose mass or powder from white to off-white.

identification

take about 30mg of this product, add 15ml of water to dissolve it, divide it into three parts, add iodine test solution, potassium iodide test solution and trinitrophenol test solution respectively, and produce brown precipitate, white precipitate and yellow precipitate respectively.
in the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.

examination

acidity 5 bottles of this product, each bottle of water lml dissolved, combined, measured according to law (General 0631 ),pH value should be 4.5~6.5.
relevant substances: take an appropriate amount of this product (about 10 mg of phentolamine mesylate), put it in a 10ml measuring flask, add the mobile phase to dissolve and dilute to the scale, shake well, and use it as a test solution; take 1ml of precision, 100ml flask, diluted with mobile phase to scale, shake, as a control solution. If there are impurity peaks in the chromatogram of the test solution, the area of impurity I peak shall not be greater than the area of the main peak of the control solution (1.0%), other single impurity peak area shall not be greater than 0.5 times (0.5%) of the main peak area of the control solution, and the sum of each impurity peak area shall not be greater than 2 times (2.0%) of the main peak area of the control solution. The chromatogram of the test solution is 0.02 times smaller than the main peak area of the control solution.
Content uniformity one bottle of this product was added with water to dissolve phentolamine mesylate and quantitatively diluted to prepare a solution containing about 0.1 mg of phentolamine mesylate per 1 ml as a test solution. Determination of phentolamine mesylate content according to the method under the item, should comply with the provisions (General 0941).
bacterial endotoxin this product, according to the law inspection (General 1143), per 1 mg phentolamine mesylate in the amount of endotoxin should be less than 5.0EU.
others should comply with the relevant provisions under injection (General 0102).

Content determination

The average value of the measurement results under the content uniformity is obtained.

category

Same as phentolamine mesylate.

specification

1Omg

storage

light shielding, closed storage.

Last Update：2022-01-01 11:39:04

Hefei TNJ Chemical Industry Co.,Ltd.

Product Name: Phentolamine Mesylate Request for quotation
CAS: 65-28-1
Tel: 0086-551-65418684
Email: sales@tnjchem.com
　　　　 info@tnjchem.com
Mobile: 0086 189 4982 3763
QQ: 2881500840

Wechat: 0086 189 4982 3763
WhatsApp: 0086 189 4982 3763
Product List: View Catalog

Shanghai Yuanye Bio-Technology Co., Ltd.

Spot supply

Product Name: Phentolamine Mesylate Visit Supplier Webpage Request for quotation
CAS: 65-28-1
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

Hefei TNJ Chemical Industry Co.,Ltd.

Product Name: Phentolamine Mesylate Request for quotation
CAS: 65-28-1
Tel: 0086-551-65418684
Email: sales@tnjchem.com
　　　　 info@tnjchem.com
Mobile: 0086 189 4982 3763
QQ: 2881500840

Wechat: 0086 189 4982 3763
WhatsApp: 0086 189 4982 3763
Product List: View Catalog

Shanghai Yuanye Bio-Technology Co., Ltd.

Spot supply

Product Name: Phentolamine Mesylate Visit Supplier Webpage Request for quotation
CAS: 65-28-1
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409

Wechat: 18301782025

View History

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 Request for Quotation

Phentolamine Mesylate

CAS: 65-28-1

Molecular Formula: C18H23N3O4S

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Names and Identifiers

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Physico-chemical Properties

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Risk and Safety

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Standard

Authoritative Data Verified Data

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Trait

Authoritative Data Verified Data

melting point

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Differential diagnosis

Authoritative Data Verified Data

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Exam

Authoritative Data Verified Data

pH

chloride

Related substances

residual solvent

loss on drying

ignition residue

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Content determination

Authoritative Data Verified Data

chromatographic conditions and system suitability test

assay

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Category

Authoritative Data Verified Data

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Storage

Authoritative Data Verified Data

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - PhentolamineMesylateTablets

Authoritative Data Verified Data

trait

identification

examination

Content determination

category

specification

storage

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine Mesilate Injection

Authoritative Data Verified Data

trait

identification

examination

Content determination

category

specification

storage

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine mesylate capsules

Authoritative Data Verified Data

trait

identification

examination

Content determination

category

specification

storage

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉 - Phentolamine mesylate for injection

Authoritative Data Verified Data

trait

identification

examination

Content determination

category

specification

storage

Supplier List

2-(N-[M-羟基苯基]-P-甲苯氨基甲基)咪唑啉